Trial record 1 of 1 for: NCT00114777
Previous Study | Return to List | Next Study
Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant (BENEFIT-EXT)
This study has been completed.
Information provided by (Responsible Party):
First received: June 17, 2005
Last updated: October 2, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||September 2014|
|Primary Completion Date:||May 2008 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||April 29, 2010|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Dobbels F, Wong S, Min Y, Sam J, Kalsekar A. Beneficial effect of belatacept on health-related quality of life and perceived side effects: results from the BENEFIT and BENEFIT-EXT trials. Transplantation. 2014 Nov 15;98(9):960-8. doi: 10.1097/TP.0000000000000159.
Pestana JO, Grinyo JM, Vanrenterghem Y, Becker T, Campistol JM, Florman S, Garcia VD, Kamar N, Lang P, Manfro RC, Massari P, Rial MD, Schnitzler MA, Vitko S, Duan T, Block A, Harler MB, Durrbach A. Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. Am J Transplant. 2012 Mar;12(3):630-9. doi: 10.1111/j.1600-6143.2011.03914.x.